Whitehawk Therapeutics, Inc. WHWK
3.06 USD -0.01 (-0.33%)
Regular-session close
3.06 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
2.91 Day range 3.11
1.99 52-week range 5.10
- YTD
- +26.45%
- 1 year
- +46.41%
- Market cap
- 180.57M
- EPS (ttm)
- -1.10
- YTD return
- +26.45%
- 1-year return
- +46.41%
- Volume
- 212.18K
- Avg volume
- 341.09K
- Open
- 3.05
- Previous close
- 3.07
- Day's range
- 2.91 – 3.11
- 52-week range
- 1.99 – 5.10
5D +0.04 (+1.32%)
Financials — quick view
WHWK Revenue — quarterly 0
WHWK Net income — quarterly -21.21M
WHWK EPS — quarterly -0.23
News
Whitehawk Therapeutics Q3 EPS $(0.23) Misses $(0.21) Estimate 
Whitehawk Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights 
Whitehawk Therapeutics Presents Two-Real World Analyses Supporting Mucin 16 
Stifel Initiates Coverage On Whitehawk Therapeutics with Buy Rating, Announces Price Target of $9 
Reported Sunday, Whitehawk's Real-World Data Show PTK7 Expression Remains Stable After Standard-Of-Care Therapies, Reinforcing Rationale For HWK-007 In EGFR Wild-Type NSCLC 
Whitehawk Therapeutics Q2 EPS $(0.20) Beats $(0.30) Estimate - Leerink Partners Initiates Coverage On Whitehawk Therapeutics with Outperform Rating, Announces Price Target of $9
12 Health Care Stocks Moving In Wednesday's Intraday Session 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
IonQ, Tempus AI And AeroVironment Are Among Top 10 Large Cap Losers Last Week (Oct. 13-Oct. 17): Are the Others in Your Portfolio?
Your note
Sign in to keep a note on WHWK — it syncs with the Stock Master app.